This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US
September 23-26, 2024
Hynes Convention CenterBoston, MA

CEVEC (Now Cytiva)


CEVEC offers high-performance cell technology for advanced bio-therapeutics manufacturing. ELEVECTA® is a large-scale production platform for AAV vectors based on inducible, helper virus-free producer cells with all necessary components stably integrated into the cell. CAP® Ad is the ideal production platform for RCA-free Adenoviral vectors and viral vaccines.